Literature DB >> 8338996

Early clinical symptoms and incidence of aspartylglucosaminuria in Finland.

M Arvio1, S Autio, P Louhiala.   

Abstract

Early clinical symptoms were analyzed from all known 43 children with aspartylglucosaminuria, born during 1974-1989 in Finland. Pre- and perinatal histories appeared normal for all children, except for muscular hypotonia and weak sucking in some babies. Three infants had abduction stiffness in the hips, needing follow-up. Other abnormalities found in infancy were umbilical or inguinal hernias and unusual susceptibility to respiratory and ear infections. This susceptibility diminished clearly in most patients after six years of age. Episodic diarrhea, described earlier, appeared to be a rather infrequent symptom and a less valuable diagnostic clue. New clinical phenomena were talipes planovalgus or clubfoot, needing surgical treatment, and aggressive behavior, needing, occasionally, child psychiatric consultation or treatment. In addition, angiokeratoma of the skin, not an infrequent phenomenon among adult patients, was found in one child. The main indications for further studies were delayed speech, attention deficit and clumsy or delayed motor functions. The disease is easily misdiagnosed and, universally, probably underdiagnosed. Its incidence in Finland was recalculated and appeared to be at least 1 in 18,500 live-born babies in this country.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338996     DOI: 10.1111/j.1651-2227.1993.tb12761.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.

Authors:  Niki Lindblom; Satu Kivinen; Hannu Heiskala; Maija-Liisa Laakso; Markus Kaski
Journal:  J Inherit Metab Dis       Date:  2006-08-30       Impact factor: 4.982

2.  Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.

Authors:  P Arvio; M Arvio; M Kero; S Pirinen; P L Lukinmaa
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

3.  Brain MRI findings in two Turkish pediatric patients with aspartylglucosaminuria.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Neuroradiol J       Date:  2016-08-22

Review 4.  Lysosomal storage diseases--the horizon expands.

Authors:  Rose-Mary Naaman Boustany
Journal:  Nat Rev Neurol       Date:  2013-08-13       Impact factor: 42.937

Review 5.  Lysosomal storage disorders: molecular basis and laboratory testing.

Authors:  Mirella Filocamo; Amelia Morrone
Journal:  Hum Genomics       Date:  2011-03       Impact factor: 4.639

Review 6.  Aspartylglycosaminuria: a review.

Authors:  Maria Arvio; Ilkka Mononen
Journal:  Orphanet J Rare Dis       Date:  2016-12-01       Impact factor: 4.123

Review 7.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.